The human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2) appear to have originated by crossspecies transmission of simian immunodeficiency virus (SIV) from asymptomatically infected African primates. Few of the SIVs characterized to date efficiently infect human primary lymphocytes. Interesting, two of the three identified to infect such cultures (SIVsm and SIVcpz) have appeared in human populations as genetically related HIVs. In the present study, we characterized a novel SIV isolate from an East African monkey of the Cercopithecus genus, the l'hoest monkey (C. l'hoesti), which we designated SIVlhoest. This SIV isolate efficiently infected both human and macaque lymphocytes and resulted in a persistent infection of macaques, characterized by high primary virus load and a progressive decline in circulating CD4 lymphocytes, consistent with progression to AIDS. Phylogenetic analyses showed that SIVlhoest is genetically distinct from other previously characterized primate lentiviruses but clusters in the same major lineage as SIV from mandrills (SIVmnd), a West African primate species. Given the geographic distance between the ranges of l'hoest monkeys and mandrills, this may indicate that SIVmnd arose through cross-species transmission from close relatives of l'hoest monkeys that are sympatric with mandrills. These observations lend support to the hypothesis that the primate lentiviruses originated and coevolved within monkeys of the Cercopithecus genus. Regarded in this light, lentivirus infections of primates not belonging to the Cercopithecus genus may have resulted from cross-species transmission in the not-too-distant past.
The human immunodeficiency virus types 1 and 2 (HIV-1 and HIV-2) are lentiviruses that appear to have originated by cross-species transmission from African primates (22, 25, 45) . Five distinct types of lentiviruses from nonhuman primates have previously been molecularly characterized: SIVsm from sooty mangabeys (Cercocebus atys) (7, 19, 37, 44) , SIVagm from the four species within the African green monkey superspecies (Cercopithecus aethiops) (3, 4, 8, 10, 11, 20, 28, 30, 38) , SIVsyk from Sykes monkeys (Cercopithecus mitis) (9, 21) , SIVmnd from mandrills (Mandrillus sphinx) (49) , and SIVcpz from chimpanzees (Pan troglodytes) (26, 27, 43, 50) . It is currently believed that these characterized viruses may represent just a small part of a very large family of primate lentiviruses. Indeed, serologic surveys of other African primates have identified a number of other monkey species that have SIV-specific antibodies (18, 33, 36, 40, 42) . For example, SIV has recently been isolated from a red-capped mangabey (Cercocebus torquatus torquatus); partial characterization of this virus suggests that it may represent a distinct (sixth) lineage, although analysis of the complete genome will be necessary to establish the exact phylogenetic relationship between SIVrcm and other primate lentiviruses (17) .
Further study of the lentiviruses infecting nonhuman primates is important because it may provide insight into the origins and evolution of HIV in humans. The phylogenetic relationships among SIVsm and HIV-2 isolates clearly implicate SIVsm as the proximal source of the HIV-2 epidemic in West Africa (13, 14, 19, 37) , but the origins of HIV-1 have not been identified with certainty. A small number of pet chimpanzees have been found to be infected with a virus (SIVcpz) closely related to HIV-1 (26, 27, 43, 50) , but the lack of serologic evidence of SIVcpz infection in feral chimpanzee populations sheds doubt on whether this virus constitutes a natural infection in this species (45) . It is intriguing that SIVs which are capable of infecting human peripheral blood mononuclear cells (PBMC) are in a minority and at least for two of these (SIVsm and SIVcpz), related HIVs (HIV-2 and HIV-1, respectively) have been demonstrated in humans. The ability to infect the CD4 ϩ lymphocytes of humans may thus be a prerequisite for cross-species transmission to humans. While the ability of these SIV strains to utilize human coreceptors is clearly one mechanism, the accessory proteins Vpr and Vif also limit the ability of some SIVs to replicate in human PBMC (46, 47) .
Among the other species of African primates identified by serologic surveys as harboring SIV are a number of species from the genus Cercopithecus, commonly called the guenons (32, 34, 41) . Cercopithecus monkeys are a diverse group of 25 species and as many as 70 subspecies of forest-dwelling monkeys that are distributed throughout subsaharan Africa (32, 34, 41) . The most commonly known members are the four species of African green monkeys (sabaeus monkeys, C. sabaeus; grivets, C. aethiops; vervets, C. pygerythrus; and tantalus monkeys, C. tantalus). Each of these four species harbors closely related SIV strains, leading to the hypothesis that the primate lentiviruses have coevolved with their host species (22, 25, 45) . The only other member of the guenons from which a novel SIV has been characterized is the Sykes monkey from which SIVsyk (9, 21) was isolated. Despite the fact that both Sykes and African green monkeys are members of the same genus, SIVsyk and SIVagm are no more closely related to one another than to any of the other characterized primate lentiviruses. Other Cercopithecus monkeys for which SIV seropositivity has been observed include DeBrazza monkeys (C. neglectus) (40) , redtailed monkeys (C. ascanius schmidtii) (20), Hamlyn's monkeys (C. hamlyni) (40) , and l'hoest monkeys (C. l'hoesti l'hoesti; 40). The close phylogenetic relationships among these monkeys and their widespread distribution across Africa, often in distinct habitats, suggest that the study of SIV in these species will enrich our understanding of the evolution of the primate lentiviruses in general and of the origins of the AIDS epidemic in humans in particular.
Molecular characterization of SIV strains from many of the African monkeys has been hampered by the lack of availability of samples from feral or wild-caught animals and the difficulty in isolating the virus. An alternative source of samples are wild-caught captive populations, such as those found at primate centers or zoo collections, although it is difficult to extrapolate that seropositivity in these populations is indicative of similar infection in free-living feral populations. In a serologic survey of a troop of l'hoest monkeys (C. l'hoesti l'hoesti) in the Portland Zoo, one wild-caught male with antibodies cross-reactive with SIVmac was identified. Here we describe the isolation of SIV from PBMC of this seropositive l'hoest monkey by cocultivation with the human T-cell line, Molt4 Clone 8 (M4C8). This isolate, designated SIVlhoest, has been characterized and compared to other known SIV sequences.
MATERIALS AND METHODS
Virus isolation and infectivity studies. Virus was isolated from PBMC of a male l'hoest monkey by coculture of phytohemagglutinin-stimulated PBMC with M4C8 cells, using production of reverse transcriptase (RT) activity in the culture supernatant as a measure of viral replication. Virus stocks were prepared from these infected cells by filtration through a 0.45-m-pore-size filter and cryopreserved in the vapor phase of liquid nitrogen for use in subsequent infectivity studies. These culture supernatants were used to infect M4C8 and CEMss cells to establish a cell line for isolation of total genomic DNA for subsequent cloning studies and for preparation of cell-free virus stocks for infectivity studies in vitro and in macaques.
Animal infectivity studies. Four juvenile (simian retrovirus-and simian T-cell leukemia virus type 1-free) pigtailed macaques (Macaca nemestrina) were inoculated intravenously with 1 ml of the uncloned SIVlhoest virus stock described above. Macaques were handled in accordance with the guidelines of the NIH Animal Care and Use Committee. Animals were subsequently monitored by virus isolation, coculture of PBMC (at 1, 2, 3, 4, 8, 12, and 16 weeks), limiting dilution infectivity assay of plasma (at 1, 2, 3, and 4 weeks), limiting dilution coculture of disrupted lymph node cells with CEMss cells (at 1, 2, 4, and 16 weeks), and in situ hybridization (ISH) of lymph node biopsies for SIVlhoest viral RNA expression. Antibody responses were monitored by Western blot analysis, using SIVlhoest virus pelleted through sucrose as the viral antigen and published Western blot procedures (24) . Lymphocyte subsets (CD4, CD8, CD2, and CD20) were analyzed at the same intervals as virus isolation assays from PBMC, and hematological alterations were monitored by performing complete blood counts.
PCR amplification and plasmid cloning. Total cellular DNA was extracted from infected CEMss cells at 10 to 15 days postinfection. Degenerate primers (LV1 and LV2 for the first round and LV3 and DDMY for the second round of amplification) designed to PCR amplify a small portion of all lentivirus pol sequences (15) were used to amplify a portion of pol from total cellular DNA. The amplification conditions were as follows: one cycle at 94°C for 2 min, 37°C for 2 min, and 72°C for 3 min, followed by 35 cycles at 94°C for 30 s, 55°C for 30 s, and 72°C for 1 min. The resulting 120-bp fragment was cloned into the TA plasmid vector (Invitrogen) and sequenced. A reverse primer was designed based on this sequence and by using a conserved forward primer situated in the primer binding site of SIVs (30), a 2.4-kb fragment was amplified using the following PCR amplification conditions: 94°C for 30 s, 55°C for 30 s, and 72°C for 2 min. This fragment was cloned into the plasmid vector pGEM-7Zf and subsequently utilized as a probe for Southern blot hybridization and screening of a bacteriophage lambda library.
Bacteriophage lambda cloning. A variety of restriction enzymes were evaluated by Southern blot hybridization of total DNA from infected CEMss cells using the 2.4-kb gag-pol virus fragment described above as a probe. Based on this analysis, SstI was chosen for full-length cloning since the proviral DNA did not appear to contain any SstI sites. Total cellular DNA was digested to completion with SstI, fractionated over a 20 to 60% sucrose gradient to obtain 9-to 20-kb fragments, and ligated into SstI-and XhoI-cleaved arms of Gem12 (Promega, Madison, Wis.). Ligation products were packaged in vitro (Gigapack Gold III; Stratagene), titrated, and plated on bacteria (Escherichia coli K802). A total of 1.5 ϫ 10 6 recombinant plaques were screened, using a horseradish peroxidaselabeled 2.4-kb gag-pol fragment and a direct detection method and following the manufacturer's instructions (ECL Direct Detection; Amersham). One positive clone (SIVlhoest-P7) was detected and plaque purified. To facilitate sequence analysis, three subgenomic clones were generated by digestion of the recombinant lambda clone with SstI and BamHI and ligation into a pGEM-7Zfϩ vector. The complete SIVlhoest provirus, including flanking cellular sequences (a 14-kb SstI fragment), was also subcloned into pGEM-7Zf to facilitate subsequent transfection studies. Both strands of the virus were sequenced by a combination of manual dideoxy sequencing using T4 sequenase (USB) and automated fluorescent sequencing (Taq amplification/termination; Perkin Elmer Applied Biosystems) in an ABI 377. Nucleotide sequence analysis was performed by using the GeneWorks (Oxford Molecular) and the Intelligenetics programs (Oxford Molecular).
Sequence comparisons. The predicted protein sequences encoded by SIV lhoest were compared to the following representatives of the major primate lentivirus lineages: HIV-1 subtype A (isolate U455; GenBank accession no. M62320), subtype B (BRU; K02013), and group O (ANT70; L20587); SIVcpz strains Gab (X52154) and Ant (U42720); SIVsm (PBj; M31325); HIV-2 subtype A (ROD; M15390) and subtype B (UC1; L07625); SIVagm from vervets (ver155; M29975), grivets (gri-1; M58410), and tantalus monkeys (tan-1; U58991); SIVsyk (173; L06042); and SIVmnd (GB1; M27470). Protein sequences were aligned using CLUSTAL X (48) with minor subsequent adjustments using SEAVIEW (12) . Sites that could not be aligned unambiguously, as well as all sites for which there was a gap in any of the sequences, were excluded from the analyses.
The extent of sequence difference, along the genome, between SIVlhoest and other viruses was examined in a diversity plot in which protein sequences were concatenated with segments encoded by overlapping genomic regions represented only once: for example, in the region of the Gag-Pol overlap, the amino terminus of the Pol protein was excluded. The fractional amino acid sequence difference was calculated for a window size of 200 residues, moved in steps of 10 residues.
The phylogenetic relationship of SIVlhoest to other primate lentivirus sequences was estimated from aligned Gag, Pol, and Env sequences and from subregions within these alignments to check for evidence that SIVlhoest might have a mosaic genome resulting from recombination during its ancestry. In the absence of such evidence, a summary phylogeny was derived from a concatenated Gag-Pol-Env alignment (the amino terminus of the Pol protein was again excluded) totaling 1,909 amino acids. Relationships were estimated by the neighbor-joining and maximum likelihood methods. The neighbor-joining method, with Kimura protein distances and 1,000 bootstrap replicates, was implemented within the CLUSTAL X package (48) . The maximum likelihood method was implemented with PROTML (1) using the JTT model. The order of sequence input was shuffled five times, with the same best tree being found each time.
Generation of ISH probes. PCR was used to amplify five 1.5-to 2-kb fragments of the SIVlhoest provirus from the complete plasmid clone by using the following primers, where the restriction sites (SstI and Csp45I) introduced to facilitate cloning are underlined: 1F, (nucleotide [nt] 1018) 5Ј-ttagagctcttgtgagaagtgtgtaa ttctgat; 1R, (nt 2482) 5Ј-tgattcgaatctgcttttgttggagcactctcc; 2F, (nt 2506) 5Ј-atcga gctcgagagcactggagacttacaggac; 2R, (nt 4505) 5Ј-atcttcgaattcctttatgagcaggcaccca tc; 3F, (nt 4529) 5Ј-attgagctctaggaggtaatcaagaggtagacc; 3R, (nt 6487) 5Ј-catttcg aataattaacactgcatacttaacat; 4F, (nt 6502) 5Ј-ttagagctcccaatactagcctctgggtcacga; 4R, (nt 8503) 5Ј-atattcgaataattaacactgcatacttaacat; 5F, (nt 8527) 5Ј-atcgagctctac ttgtaatcatagggttaagag; 5R, (nt 9844) 5Ј-taattcgaaactagcttgtactttctaacaatg.
These five fragments were cloned into pGEM-7Zf, the subsequent clones were digested with SstI (antisense) and Csp45I (sense), and RNA was transcribed to incorporate digoxigenin using Sp6 and T7 polymerase, respectively. The pooled antisense probe was used to detect viral mRNA expression in lymph node biopsy samples that were fixed in STRECKS fixative using previously described methodology (24).
Transfection and infectivity studies. Virus stocks were generated by transfection of 5 to 10 g of either the lambda or plasmid clone into 293 cells by a calcium phosphate-mediated procedure (CellPhect; Stratagene). The infectivity of these filtered supernatants was evaluated by infection of CEMss cells, macaque PBMC, and macaque monocyte-derived macrophages as previously described (24) .
Nucleotide sequence accession number. The complete sequence of SIVlhoest has been submitted to GenBank under accession no. AF075269.
RESULTS

Infectivity and pathogenicity of SIVlhoest in vivo.
SIVlhoest was clearly distinct from other primate lentiviruses, such as SIVagm, SIVsm, or HIV-1, since the Gag antigens in culture supernatants of persistently infected cells did not cross-react with a commercially available SIVmac p27 antigen capture assay (Coulter Corp.). As a prelude to any in vivo characterization, the infectivity of SIVlhoest for macaque and human PBMC was compared to that of representative members of the SIVsm, SIVsyk, SIVagm, and HIV-1 lineage (Fig. 1) . Like SIVsmE543-3, SIVlhoest infected both human and macaque PBMC efficiently. This contrasted with the restricted tropism of SIVsyk for Sykes monkey PBMC (not shown), SIVagm for macaque PBMC, and HIV-1 for human PBMC.
Infectivity in macaque PBMC is a prerequisite for a robust infection in vivo but clearly is not predictive of pathogenicity for that species. To evaluate the potential pathogenicity of SIVlhoest, a cohort of four pigtailed macaques (M. nemestrina) was inoculated intravenously with uncloned SIVlhoest. Since this latter virus had been passaged twice through human T-cell lines, which might produce attenuation, we also isolated virus from a homogenate of cryopreserved spleen from the same l'hoest monkey by short-term coculture with M4C8 cells (4 days) and subsequent infection of macaque PBMC. This virus was designated SIVlhoest-S to distinguish it from the PBMC isolate; four additional pigtailed macaques were inoculated intravenously with this primary virus isolate.
Each of the macaques became persistently infected, as evidenced by isolation of virus from PBMC and lymph node biopsies at multiple time points postinoculation ( Table 1) . The macaques inoculated with the virus isolate from PBMC (macaques 622, 623, 626, and 627) that was passaged twice in human T-cell lines exhibited less-consistent virus isolation than macaques inoculated with the splenic isolate (macaques 633, 634, 635, and 636), which is suggestive of some degree of viral attenuation of the PBMC isolate. However, one of these (macaques 622) exhibited the most profound and early CD4 depletion of all the inoculated animals. Each macaque exhibited an early decline in all lymphocyte subsets (CD4 subset shown in Fig. 2A) , reaching a lowest point at 1 week postinoculation. Lymphopenia was coincident with peak levels of infectious SIV in the plasma (1,000 50% tissue culture infectious doses/ml) and a high proportion of SIV-expressing cells within lymph nodes, as demonstrated by limiting dilution coculture of disrupted lymph node cells with CEMss cells (1 in 1,000 cells) . High lymphoid virus expression was confirmed by ISH with SIVlhoest-specific riboprobes (Fig. 3) . The plasma viremia resolved by 3 weeks, with declining prevalence of SIV-expressing cells in lymph nodes; this phase was associated with the onset of massive lymphoid hyperplasia and the trapping of virions in a pattern characteristic of the distribution of follicular dendritic cells in germinal centers (6) . Subsequent fluorescenceactivated cell sorter analysis of lymphocyte subsets revealed a gradual decline (2-to 10-fold) in the numbers of circulating CD4 ϩ lymphocytes, similar to that observed in a cohort of six pigtailed macaques inoculated with a pathogenic uncloned SIVsm isolate (SIVsmE660; Fig. 2B ). As was also observed with SIVsmE660 (22) , the severity of the CD4 decline in PBMC 622 ϩϩ ϩϩ ϩϩ ϩ ϩ ϩϩ ϩ Ϫ Ϫ ϩ ϩ ϩ 623 ϩϩ ϩϩ ϩϩ Ϫ Ϫ ϩϩ Ϫ Ϫ Ϫ Ϫ ϩ Ϫ 626 ϩϩ ϩϩ ϩϩ ϩ Ϫ ϩϪ Ϫ Ϫ Ϫ Ϫ Ϫ Ϫ 627 ϩϩ ϩϩ ϩϩ ϩ Ϫ ϩϩ ϩ ϩ ϩ Ϫ ϩ Ϫ Spleen 633 ϩϩ ϩϩ ϩϩ ϩ ϩ ϩϩ Ϫ ϩ ϩ Ϫ ϩ ϩ 634 ϩϩ ϩϩ ϩϩ ϩ ϩ ϩϩ ϩ ϩ ϩ ϩ Ϫ ϩ 635 ϩϩ ϩϩ ϩϩ ϩ ϩ ϩϩ ϩ ϩ ϩ ϩ ϩ ϩ 636 ϩϩ ϩϩ ϩϩ ϩ ϩ ϩϩ Ϫ Ϫ Ϫ Ϫ Ϫ ϩ a Virus isolation from PBMC and lymph nodes as detected by RT activity in culture supernatant within a 6-week period of coculture is indicated by a ϩ, and inability to isolate virus is indicated by a Ϫ.
SIVlhoest-infected macaques varied considerably, from mild to profound depletion. The macaque that exhibited the most severe CD4 depletion (macaque 622) has also failed to gain weight and exhibits mild anemia (hematocrit of 28%), thrombocytopenia (Ͻ30,000 per l), and periodic bouts of diarrhea. Two other macaques currently exhibit mild weight loss in association with peripheral CD4 lymphocytes of less than 500 per l.
SIVlhoest is a novel member of the SIVmnd lineage. In order to characterize SIVlhoest molecularly, we used degenerate primers to amplify a 120-bp fragment of the pol gene from cellular DNA extracted from infected M4C8 cells. This fragment was cloned, and based on the sequence, we designed a reverse primer in pol that was used in combination with a forward primer in the highly conserved primer binding site to amplify and clone a 2.4-kb gag-pol fragment. This fragment was used as a probe in a subsequent Southern blot hybridization to identify restriction enzymes useful for cloning and as a probe to identify proviruses within a bacteriophage lambda library generated by SstI digestion of cellular DNA extracted from infected M4C8 cells. One full-length clone, SIVlhoest-P7 was obtained and purified. SIVlhoest-P7 was infectious after transfection of M4C8 or CEMss cells and subsequent infection of macaque and human PBMC. After being subcloned into plasmid vectors, the proviral portion of the clone was sequenced in its entirety (9,957 nt) and compared to the sequences of other known primate lentiviruses.
The genomic organization of SIVlhoest was similar to that of SIVagm, SIVmnd, and SIVsyk. Each of these viruses encodes gag, pol, and env, as well as the accessory genes vif, vpr, tat, rev, and nef, but lacks the additional genes vpu (found only among the members of the HIV-1 and SIVcpz lineage) and vpx (specific to SIVsm, SIVmac, and HIV-2). The long terminal repeat (LTR) of SIVlhoest (789 nt) contained all the characteristic features of other primate lentivirus LTRs, including one NF-B site and two potential SP-1 binding sites (data not shown). Comparisons of the predicted protein sequences encoded by the eight common genes revealed that SIVlhoest was quite distinct from all other SIV (and HIV) isolates analyzed to date, exhibiting at least 33% amino acid sequence difference from representatives of each of the five lineages of primate lentiviruses (Table 2) . For the large genes gag, pol, and env, as well as for vpr and tat, the SIVlhoest proteins were most similar to those of SIVmnd, but for the vif, rev, and nef genes, the distance between the SIVlhoest and SIVmnd proteins was similar to that between SIVlhoest and other SIVs. The similarity between SIVlhoest and SIVmnd is shown in an alignment of the surface unit (SU) portion of the Env protein of these two viruses (Fig. 4) . Although scattered substitutions are evident throughout gp120, many of the cysteine residues (asterisks) and potential N-linked glycosylation sites were conserved and regions such as the V3 loop analog and the CD4 binding domain showed remarkable conservation. The sequence of the envelope amplified from the spleen of the l'hoest monkey (lhoest-S) had 95% identity with that of the infectious clone (lhoest-7). These two envelope sequences are representative of the two isolates used to inoculate the macaques. As expected from other primate lentivirus envelopes, the V1 region was the most variable, with characteristic threonine residues and insertion/deletion polymorphism. In contrast, the CD4 binding domain was absolutely conserved and only one substitution was observed in the V3 loop analog.
To examine the divergence of SIVlhoest from the other primate lentiviruses in more detail, the extent of sequence difference was determined for moving windows of 200 amino acids. The resulting diversity plot confirmed that overall, SIVlhoest is most similar to SIVmnd but in some segments these two viruses are about as different from each other as they are from other SIVs (Fig. 5) . Furthermore, that plot showed that the boundaries of these regions lie within genes, so that each of the major genes (gag, pol, and env) includes segments of both types. This variation in the extent of relative divergence between SIVlhoest and SIVmnd (i.e., relative to the extent of divergence from other SIVs) could indicate that the ancestors VOL. 73, 1999 NOVEL SIV FROM L'HOEST MONKEYSof these viruses were generated by recombination of different SIV lineages, as has been found for SIVagm from sabaeus monkeys (29) . To examine the evolutionary relationship of SIVlhoest to the other primate lentiviruses, we generated numerous phylogenetic trees derived from alignments of individual gene products and from smaller regions defined by consideration of the diversity plot (data not shown). These all indicated a clustering of SIVlhoest with SIVmnd, though their relative distances varied. Thus, these analyses provided no evidence that recombination has played a significant role in the evolution of SIVlhoest (or SIVmnd) and suggested that the variation in the extent of relative divergence between SIVlhoest and SIVmnd reflects changes in rates of evolution specific to these viruses.
Since the SIVlhoest-SIVmnd clade was maintained across all of the analyses, an overview of the phylogenetic relationships between these viruses was obtained from an analysis of an alignment of concatenated Gag-Pol-Env proteins, in which SIVlhoest appears as a highly divergent member of the same major lineage as SIVmnd (Fig. 6) . The interpretation that SIVlhoest and SIVmnd are members of the same clade is dependent on the position of the root of the phylogenetic tree; the tree shown in Fig. 6 has been midpoint rooted. The "precise" position of the root of the primate lentivirus tree is problematic, since the nearest available outgroup sequences, namely, lentiviruses from other mammalian hosts, are quite distantly related. However, analyses using various such outgroups suggest that the rooting shown in Fig. 6 is appropriate. Importantly, none of our analyses using nonprimate lentivirus outgroups ever placed the root in such a position as to disrupt the SIVlhoest-SIVmnd clade. Thus, we conclude that SIVlhoest and SIVmnd are both members, albeit distantly SIVmnd  54  67  38  65  43  32  51  44  SIVsyk  48  51  31  21  31  19  35  40  SIVagm  49  57  41  42  41  32  36  41  SIVsm  49  58  30  42  35  30  35  43  SIVcpz  49  58  33  41  26  19  30  41 a Identities were calculated as described in the "Sequence comparisons" section of Materials and Methods. SIVagm  77  70  57  76  57  53  70  73  SIVcpz  68  74  57  64  58  54  51  53 a Identities were calculated as described in the "Sequence comparisons" section of Materials and Methods. related, of the same major primate lentivirus lineage. Overall, SIVlhoest and SIVmnd are rather more divergent from each other than are SIVs from different species of African green monkey ( Table 3 ). The only other example of such high divergence within a major lineage involves the SIVcpz-HIV-1 lineage, where SIVcpz/Ant is almost as different from SIVcpz/Gab1 (Table 3) and HIV-1 as SIVlhoest and SIVmnd are from each other.
DISCUSSION
It seems clear that HIV-1 originated through cross-species transmission(s) in the recent past from a naturally infected African primate, but the species involved remains open to question. Therefore, further exploration of the nature of the diversity among primate lentiviruses is necessary to elucidate the origins and evolution of the human viruses. Now that we have characterized SIVlhoest and examined the relationship between it and the previously known primate lentiviruses, it is clear that this particular virus is not the proximal source of HIV-1. However, the phylogenetic position of SIVlhoest is surprising and has implications for our understanding of primate lentivirus evolution. In particular, at first sight, the genetic similarity between SIVlhoest and SIVmnd seems difficult to explain.
While the phylogeny of the primate lentiviruses indicates that there have been multiple cross-species transmissions (45) , there are also indications that some of the viruses have co- evolved with their natural host species and thus that the group as a whole may be quite ancient. The four species of African green monkeys (vervets, grivets, and sabaeus and tantalus monkeys) each harbor their own variants of SIVagm, while SIVsyk and now SIVlhoest are rather more divergent viruses from rather more divergent Cercopithecus species. It is tempting to speculate that these Cercopithecus SIVs represent the vertical transmission "backbone" of the primate lentivirus phylogeny, with the other SIVs from more distantly related primates having all resulted from horizontal transmissions. Whether this scenario is accurate, the comparatively close relationship between SIVlhoest and SIVmnd seems most unlikely to be a reflection of host-dependent viral evolution, since the mandrill belongs to a genus (Mandrillus) quite distant from the Cercopithecus genus, and so (at least) one of these viruses is likely the result of cross-species transmission. There is accumulating evidence that such transfer of SIV does occur naturally between different species of monkeys that share a common habitat in the wild. For example, the sabaeus subtype of SIVagm has been identified in wild-caught patas monkeys (Erythorocebus patas) in West Africa (5) and the vervet subtype of SIVagm has been found in a yellow baboon (Papio hamadryas cynocephalus) in Tanzania (29) . However, mandrills are restricted to the west coastal region of central Africa around Gabon, whereas l'hoest monkeys inhabit a localized area of central Africa more than 1,000 km to the east (Fig. 7) (32, 34, 42) .
The geographical separation of l'hoest monkeys and mandrills implies that neither could be the immediate source of virus for the other. However, close relatives of l'hoest monkeys are found in regions of west central Africa overlapping the mandrill range (Fig. 7) . Preussis monkeys (C. preussi preussi and insularis) from Cameroon and Bioko Island and sun-tailed monkeys (C. solatus) from Gabon are sufficiently similar to l'hoest monkeys that they have been considered by some to be a subspecies of C. lhoesti. Furthermore, at least one of these species, C. solatus, has serologic evidence of SIV infection (25a). We therefore hypothesize that SIVmnd infection of mandrills resulted from cross-species transmission of SIV from one of these relatives of the l'hoest monkey. This direction of the transmission, rather than from mandrill to the l'hoest monkey, is consistent with the Cercopithecus origin of primate lentiviruses suggested above and is supported by the apparently low rate of SIV seroprevalence in wild mandrills. Only two seropositive wild-caught mandrills have been reported, and the only existing clone came from one of two seropositive founders of a colony in Gabon. Although SIVmnd is now prevalent within this colony, all of the circulating viruses appear to be highly related, suggesting subsequent transmission of this virus within the colony (16, 39) . It will be interesting to determine whether feral mandrills from other locations also harbor SIVmnd.
Consistent with the proposed ancient relationship between primate lentiviruses and their respective natural hosts, SIVs appear to result in an asymptomatic infection in their natural host species (e.g., SIVsm in sooty mangabeys or SIVagm in African green monkeys) (24) . However, AIDS may result upon experimental infection of other primates, particularly macaques (2, 7, 22, 24, 35) . In the present study, SIVlhoestinfected macaques demonstrated many of the virologic, immunologic, and clinical characteristics of early infection of macaques with pathogenic isolates of SIVsm, SIVmac, or SIVagm. Such characteristics included (i) high viral expression in lymphoid tissues in the primary phase of infection, (ii) high primary plasma viremia, (iii) subsequent lymphadenopathy and trapping of viral RNA in germinal centers in a follicular dendritic cell pattern, (iv) declining peripheral CD4 lymphocyte numbers, (v) persistent PBMC-associated viremia, and (vi) thrombocytopenia and weight loss in one macaque. Although these animals have not been infected for a sufficient period of time to become symptomatic, the virologic and clinical features of infection are consistent with progression to AIDS. Moreover, SIVlhoest appears to be directly pathogenic for macaques without adaptation by prior macaque passage.
The ability of SIVlhoest to infect human PBMC in vitro at least as efficiently as it infects macaque PBMC suggests that this virus has the potential to infect human populations. Such cross-species transmission to humans has already been observed for the SIVsm isolate that is now circulating among human populations as HIV-2 (13, 14) . While the ability of this virus to infect human PBMC may not be predictive of virulence in humans, serologic surveys of humans in regions near the habitat of l'hoest monkeys are necessary to evaluate this possibility. These highly specialized forest dwellers have considerably less contact with humans than species such as sooty mangabeys. However, the continued expansion of human populations and encroachment upon the habitats of primates such as the l'hoest monkey may amplify the risk for such an event in the future. VOL. 73, 1999 NOVEL SIV FROM L'HOEST MONKEYS
